연구성과로 돌아가기
2022 연구성과 (219 / 280)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| WoS | SCOPUS | Document Type | Document Title | Abstract | Authors | Affiliation | ResearcherID (WoS) | AuthorsID (SCOPUS) | Author Email(s) | Journal Name | JCR Abbreviation | ISSN | eISSN | Volume | Issue | WoS Edition | WoS Category | JCR Year | IF | JCR (%) | FWCI | FWCI Update Date | WoS Citation | SCOPUS Citation | Keywords (WoS) | KeywordsPlus (WoS) | Keywords (SCOPUS) | KeywordsPlus (SCOPUS) | Language | Publication Stage | Publication Year | Publication Date | DOI | JCR Link | DOI Link | WOS Link | SCOPUS Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ○ | ○ | Article | Computed tomographic findings of primary renal tumors in dogs and cats | Primary renal tumor is uncommon in dogs and cats, with few previous computed tomography (CT) reports. Previous studies have reported that contrast-enhancing CT is helpful in differentiating the type of renal tumors. This study aimed to describe CT findings of renal tumors in dogs and cats and identify contrast-enhancing pattern according to 3 post-contrast phases. In this retrospective study, the following CT findings were recorded for each patient: (1) renal tumor involvement, (2) enhancement pattern, (3) vascular invasion, (4) presence of lymphadenopathy and organ metastasis, (5) presence of mineralization, and (6) attenuation values of renal tumors on pre- and post-contrast corticomedullary, nephrographic and excretory phase images. Eight dogs and 2 cats met the inclusion criteria, of which 7 had renal cell carcinoma, 2 had lymphoma and one had nephroblastoma. Renal cell carcinomas tended to show heterogeneous and progressive contrast enhancement, unilateral renal involvement and relatively high incidence of lymphadenopathy. Renal lymphomas showed heterogeneous and progressive contrast enhancement and bilateral renal involvement. Nephroblastoma showed heterogeneous and plateau pattern of contrast enhancement and unilateral renal involvement. Findings from the current study support that CT with triphasic contrast study is helpful in renal tumor characterization and vascular invasion and metastasis evaluation. Further large-scale studies are necessary to examine the association between CT and histopathological findings. | Noh, Daji; Shim, Jaejin; Choi, Sooyoung; Choi, Hojung; Lee, Youngwon; Lee, Kija | Kyungpook Natl Univ, Dept Vet Med Imaging, Coll Vet Med, Daegu 41566, South Korea; 24 Africa Anim Med Ctr, Daejeon 35261, South Korea; Dodo Anim Clin, Sacheon 52532, South Korea; Kangwon Natl Univ, Dept Vet Med Imaging, Coll Vet Med, Chunchon 24341, South Korea; Chungnam Natl Univ, Dept Vet Med Imaging, Coll Vet Med, Daejeon 34134, South Korea | 57188552722; 57936225800; 55736574600; 35202930200; 8983566800; 35311016000 | leekj@knu.ac.kr; | THAI JOURNAL OF VETERINARY MEDICINE | THAI J VET MED | 0125-6491 | 52 | 3 | SCIE | VETERINARY SCIENCES | 2022 | 0.4 | 87.2 | 0.43 | 2025-06-25 | 2 | 2 | canine; computed tomography; feline; renal mass | CELL CARCINOMA; LYMPHOMA; ENHANCEMENT; CT; DIFFERENTIATION; PROGNOSIS; PATTERNS; FEATURES; MASSES | canine; computed tomography; feline; renal mass | alanine aminotransferase; alkaline phosphatase; amylase; butorphanol; cholesterol; creatinine; iohexol; isoflurane; midazolam; phosphorus; propofol; animal experiment; animal model; animal tissue; Article; attenuation; cat; computer assisted tomography; contrast enhancement; cytology; dog; enhancement pattern; hematocrit; hematological parameters; histopathology; image analysis; kidney tumor; lymphadenopathy; metastasis; mineralization; multidetector computed tomography; nephroblastoma; nonhuman; physical examination; renal cell carcinoma; renal lymphoma; renography; retrospective study; tumor invasion; urea nitrogen blood level; vascular invasion | English | 2022 | 2022-09 | 10.14456/tjvm.2022.57 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Effect of Electrical Conductivity on Atomization Characteristics of Electrospray | This study experimentally investigated various spraying modes in electrospraying, an atomization method in which a high voltage is applied to the auxiliary device at the tip of the nozzle. The spraying modes were generated depending on the experimental parameters (voltage, current, and flow rate) and characteristics of two test solutions (S and C), which were a mixture of ethanol, glycerol, citric acid, and water. Solution C had a higher electrical conductivity than solution S. Eleven spray modes were identified in the study. From a comparison of the spray modes, a maximum Sauter mean diameter (SMD) of the cone jet of solution S was 1.7 times that of solution S. The standard deviation of SMD for the unstable, rotating-jet, and pulsed-jet modes were more than two times that for the cone-jet mode. With an increase in flow rate in the cone jet, the SMD and SMD standard deviation of solution C increased linearly, and the SMD value of solution C was ???5% lower than that of solution B. The SMD standard deviations for both S and C solutions were small at low flow rates, and the standard deviation for solution C (with high conductivity) was smaller than that of solution S. For a given SMD, the current associated with solution C was higher than that associated with solution S. The study presented the comprehensive data for SMD, SMD standard deviation, and current in an electrospray system for the two fluids of different electrical conductivities under various experimental conditions. | Kim, J. Y.; Hong, J. G. | Kyungpook Natl Univ, Sch Mech Engn, Bukgu 41566, Daegu, South Korea | 57222525959; 24576652200 | jghong70@knu.ac.kr; | JOURNAL OF APPLIED FLUID MECHANICS | J APPL FLUID MECH | 1735-3572 | 1735-3645 | 15 | 5 | SCIE | MECHANICS;THERMODYNAMICS | 2022 | 1 | 87.2 | 0.35 | 2025-06-25 | 5 | 4 | Electrospray; Conductivity; Wide cone jet; Sauter mean diameter; Standard deviation; SMD-current | BREAK-UP; JET; NANOPARTICLES | Conductivity; Electrospray; Sauter mean diameter; Smd-current.; Standard deviation; Wide cone jet | English | 2022 | 2022-09 | 10.47176/jafm.15.05.1094 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | The breed-specific vertebral heart score and vertebral left atrial size in toy breed dogs | Vertebral heart score (VHS) and vertebral left atrial size (VLAS) are the objective measures of cardiac and left atrial sizes on thoracic radiographs in dogs. Previous studies have demonstrated that the normal VHS reference ranges can vary among breeds. This retrospective study aimed to evaluate the VHS and VLAS of healthy Maltese, Pomeranian, and Toy Poodle dogs, which were predisposed to cardiac disease. Fifty Maltese, 47 Pomeranian, and 45 Toy Poodles were enrolled. The VHS of Maltese, Pomeranian and Toy Poodles was 9.69 +/- 0.51, 10.69 +/- 0.62, and 9.94 +/- 0.60, respectively. The VHS of Pomeranian and Toy Poodles were significantly higher than the canine reference value of 9.7 vertebrae. The VLAS of Maltese, Pomeranian and Toy Poodles was 2.03 +/- 0.17, 2.17 +/- 0.26, and 2.02 +/- 0.15, respectively. Compared to the reference value of 1.9 vertebrae, the VLAS of Maltese, Pomeranian and Toy Poodles was significantly higher. The VHS and VLAS of Pomeranians were significantly higher than those of Maltese and Toy Poodles. The cardiomegaly or left heart enlargement could be overdiagnosed in healthy Maltese, Pomeranian and Toy Poodles, especially Pomeranians, therefore, the VHS and VLAS values in this study could be used as references. | Na, Hyemin; Lee, Yeseong; Lee, Sang -Kwon; Choi, Hojung; Lee, Youngwon; Lee, Kija | Kyungpook Natl Univ, Coll Vet Med, Dept Vet Med Imaging, Daegu 41566, South Korea; Chungnam Natl Univ, Coll Vet Med, Dept Vet Med Imaging, Daejeon 34134, South Korea | 57219434344; 58189149900; 56494541400; 35202930200; 8983566800; 35311016000 | leekj@knu.ac.kr; | THAI JOURNAL OF VETERINARY MEDICINE | THAI J VET MED | 0125-6491 | 52 | 4 | SCIE | VETERINARY SCIENCES | 2022 | 0.4 | 87.2 | 0 | 2025-06-25 | 0 | 0 | canine; thoracic radiograph; VHS; VLAS | MITRAL-VALVE DISEASE; THORACIC RADIOGRAPHS; SCALE; SURVIVAL; RANGES | canine; thoracic radiograph; VHS; VLAS | Article; body mass; color Doppler flowmetry; confidence interval; cross-sectional study; echocardiography; heart; heart left atrium; left atrial function; mitral valve disease; nonhuman; prospective study; reference value; retrospective study; thorax radiography; vertebra; Vertebral heart score; vertebral left atrial size | English | 2022 | 2022-12 | 10.14456/tjvm.2022.87 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Association of MGMT Gene Promoter Methylation With Clinicopathological Parameters in Patients With Wild-type IDH Glioblastoma | Background: The methylation status of the O-6-methylguanine-DNA methyltransferase (MGMT) promoter plays a key role in response to temozolomide chemotherapy and disease prognosis in patients with wild-type isocitrate dehydrogenase (IDH) glioblastoma (GBM). Patients and Methods: The MGMT promoter methylation status and its association with clinicopathological parameters were retrospectively analysed in a cohort of 316 patients with GBM with wild-type IDH. Results: MGMT methylation was significantly associated with ATRX chromatin remodeler (ATRX) loss and completion of the standard Stupp protocol. The median durations of overall and progression-free survival for the unmethylated, low-methylated (10-39%), and hypermethylated (>= 40%) groups were 15, 23, and 30 months and 11, 18, and 21 months, respectively. However, the improvement in the survival of the hypermethylated group was not statistically significant. Conclusion: We suggest a possible association between MGMT methylation status and ATRX mutations in GBM with wild-type IDH. | Kim, Moonsik; Yoo, Jihwan; Chang, Jong Hee; Kim, Se Hoon | Kyungpook Natl Univ, Sch Med, Chilgok Hosp, Dept Pathol, Daegu, South Korea; Yonsei Univ, Coll Med, Severance Hosp, Brain Tumor Ctr,Dept Neurosurg, 50 Yonsei Ro, Seoul 03722, South Korea; Yonsei Univ, Coll Med, Severance Hosp, Dept Pathol, 50 Yonsei Ro, Seoul 03722, South Korea | ; Kim, Soo/P-7880-2016; Yoo, Jihwan/ABG-4520-2021 | 57195918515; 57216976437; 7601549862; 57307208200 | changjh@yuhs.ac;PAXCO@yuhs.ac; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 42 | 1 | SCIE | ONCOLOGY | 2022 | 2 | 87.3 | 0.47 | 2025-06-25 | 6 | 5 | MGMT; methylation status; ATRX loss; hypermethylation; low methylation; glioblastoma; temozolomide chemotherapy; wild-type IDH; glioblastoma | NEWLY-DIAGNOSED GLIOBLASTOMA; TEMOZOLOMIDE; BENEFIT; CONCOMITANT; MULTIFORME; EXPRESSION; MUTATIONS; PROTEIN; EXTENT; ATRX | ATRX loss; Glioblastoma; Glioblastoma; Hypermethylation; Low methylation; Methylation status; MGMT; Temozolomide chemotherapy; Wild-type IDH | Aged; Biomarkers, Tumor; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Female; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Prognosis; Progression-Free Survival; Promoter Regions, Genetic; Retrospective Studies; Temozolomide; Tumor Suppressor Proteins; X-linked Nuclear Protein; epidermal growth factor receptor; isocitrate dehydrogenase; Ki 67 antigen; methylated DNA protein cysteine methyltransferase; protein p53; transcriptional regulator ATRX; ATRX protein, human; DNA ligase; DNA methyltransferase; isocitrate dehydrogenase; MGMT protein, human; temozolomide; transcriptional regulator ATRX; tumor marker; tumor suppressor protein; adult; Article; bisulfite sequencing; cancer prognosis; clinical assessment; cohort analysis; controlled study; DNA extraction; DNA methylation; female; fluorescence in situ hybridization; gene amplification; gene mutation; genetic association; glioblastoma; human; human tissue; immunohistochemistry; Karnofsky Performance Status; major clinical study; male; overall survival; paraffin embedding; progression free survival; promoter region; pyrosequencing; retrospective study; Sanger sequencing; tumor volume; aged; DNA methylation; drug effect; genetics; glioblastoma; middle aged; mutation; pathology; prognosis; promoter region | English | 2022 | 2022-01 | 10.21873/anticanres.15490 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | Change of RBC Deformability During Hematopoietic Stem Cell Transplantation | The red blood cell (RBC) deformability test is the measurement of the ability of RBCs to adapt their shape to the flow conditions. The major determinants of RBC deformability include cell shape, composition of the cell membrane and cytoskeleton, and internal viscosity (mean cell hemoglobin concentration). RBC deformability is primarily regulated by the composition and arrangement of the cell membrane. In cancer patients, chemotherapy and hematopoietic stem transplantation (HSCT) affect the bone marrow microenvironment, which may alter RBC production and deformability. We aimed to evaluate the change in RBC deformability during HSCT. Blood samples were obtained from patients who underwent HSCT. Eleven children were enrolled in this study. RBC deformability was measured with a microfluidic ektacytometer (RheoScan-D, RheoMeditech, Seoul, Korea). All analyses were completed within 24 hours after blood collection. The elongation index of the erythrocytes was measured. The elongation index of RBCs gradually increased from day 5 to day 30 after HSCT. RBC deformability may reflect the bone marrow microenvironment of the patient during HSCT. Further studies investigating the correlation between RBC deformability and the prognosis of HSCT are needed. | Kim, Yu Kyung; Lee, Jae Min | Kyungpook Natl Univ, Dept Clin Pathol, Sch Med, Daegu, South Korea; Yeungnam Univ, Coll Med, Dept Pediat, Daegu 42415, South Korea | Lee, Jae Min/H-8475-2013 | 9237571900; 39261799700 | mopic@hanmail.net; | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | J PEDIAT HEMATOL ONC | 1077-4114 | 1536-3678 | 44 | 2 | SCIE | HEMATOLOGY;ONCOLOGY;PEDIATRICS | 2022 | 1.2 | 87.3 | 0.4 | 2025-06-25 | 3 | 3 | RBC deformability; stem cell transplantation; ektacytometer | OSMOTIC GRADIENT EKTACYTOMETRY; DIABETES-MELLITUS; BONE-MARROW; HEREDITARY SPHEROCYTOSIS; BLOOD TRANSPLANTATION; VALIDATION; STRESS | ektacytometer; RBC deformability; stem cell transplantation | Child; Erythrocyte Deformability; Erythrocytes; Hematologic Tests; Hematopoietic Stem Cell Transplantation; Humans; Republic of Korea; article; blood sampling; bone marrow; cancer patient; chemotherapy; child; controlled study; erythrocyte deformability; hematopoietic stem cell transplantation; human; human cell; human tissue; microenvironment; prognosis; South Korea; blood examination; erythrocyte | English | 2022 | 2022-03 | 10.1097/mph.0000000000002295 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | Clinicopathological Characteristics of Advanced Epstein-Barr Virus-associated Gastric Cancer Highlighting Aberrant p53 Expression | Background/Aim: Epstein-Barr virus (EBV)-associated gastric cancer is a distinct subtype of stomach adenocarcinoma. Although previous studies have investigated its clinicopathological characteristics, there is a lack of research focusing on advanced EBV-associated gastric cancer. In this study, we performed a comprehensive review of advanced EBV-associated gastric cancer cases. Patients and Methods: We retrospectively collected 18 consecutive cases of surgically resected advanced EBV-associated gastric cancer. Clinicopathological parameters were investigated using histological review, immunohistochemistry, and a review of the electronic medical records of the hospital. Results: The predominant histological pattern of advanced EBV-associated gastric cancer, according to the Lauren classification, was intestinal-type adenocarcinoma with varying degrees of differentiation. However, focal areas showing conventional gastric carcinoma with a lymphoid stromal pattern were found in all cases except one. In addition to the previously described histological patterns of EBV-associated gastric cancer, one case displayed chronic granulomatous inflammation-like histology with barely identifiable malignant epithelial cells. Another case had a pure signet-ring cell carcinoma component showing nuclear positivity for the EBV-encoded RNA in situ hybridization assay. Remarkably, five out of 18 cases (27.8%) showed aberrant p53 expression on immunostaining, which is known to occur rarely in EBV-associated gastric cancer. All cases with aberrant p53 expression had intestinal-type adenocarcinoma-like components. Conclusion: Advanced EBV-associated gastric cancer had distinct histology and a higher rate of aberrant p53 immunostaining pattern than conventional EBV-associated gastric cancer. Therefore, their biological behavior should be investigated separately. | Jang, Hyeonguk; Seo, An Na; Kim, Moonsik | Yonsei Univ, Severance Hosp, Coll Med, Dept Pathol, Seoul, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Pathol, Daegu, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Daegu 41405, South Korea | 57913586900; 55804153700; 57195918515 | san_0729@naver.com;teiroa83@knu.ac.kr; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 42 | 10 | SCIE | ONCOLOGY | 2022 | 2 | 87.3 | 0.19 | 2025-06-25 | 2 | 2 | Epstein-Barr virus; advanced gastric cancer; gastric carcinoma with lymphoid stroma; p53 | IMMUNOHISTOCHEMICAL STAINING PATTERNS; LYMPHOID STROMA; CARCINOMA; ADENOCARCINOMA; FEATURES | advanced gastric cancer; Epstein-Barr virus; gastric carcinoma with lymphoid stroma; p53 | Adenocarcinoma; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Retrospective Studies; RNA; Stomach Neoplasms; Tumor Suppressor Protein p53; protein p53; protein p53; RNA; adult; advanced cancer; aged; Article; cancer classification; cancer diagnosis; cancer staging; cancer surgery; clinical article; controlled study; disease association; electronic medical record; epithelioid histiocyte; Epstein Barr virus infection; female; granulomatous inflammation; human; immunohistochemistry; lymph node metastasis; lymph vessel metastasis; male; microsatellite instability; middle aged; missense mutation; perineural invasion; retrospective study; RNA probe; signet ring carcinoma; stomach adenocarcinoma; stomach cancer; total gastrectomy; tumor volume; adenocarcinoma; Epstein Barr virus; Epstein Barr virus infection; genetics; pathology; stomach tumor | English | 2022 | 2022-10 | 10.21873/anticanres.16002 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Comparison of Survival Outcomes Based on Pre-treatment Pleural Effusion in Advanced Epithelial Ovarian Cancer | Background/Aim: The influence of pleural effusion (PE) on survival outcomes in ovarian cancer has not been thoroughly evaluated. This study aimed to analyze the effect of pre-treatment PE on prognosis. Patients and Methods: A total of 117 patients with stage III and IV epithelial ovarian cancer having pre-treatment PE were included in the study. Malignant PE was determined with CT or PET/CT or biopsy. Results: Thirty patients (27.0%) had PE and 81 (73.0%) had no PE (NPE). For first-line chemotherapy, the delivered dose intensity was significantly higher in PE. In both groups, 5-year overall survival (OS) and progression-free survival (PFS) did not present statistical significant differences. The 7-year PFS of PE was significantly shorter unlike the OS. Conclusion: Within 5 years, pre-treatment PE did not have a significant impact on OS nor PFS for patients with a higher dose of first-line chemotherapy. Within 7 years, better management strategies are needed as PE can have a negative impact on PFS. | Lee, Juhun; Hong, Dae Gy | Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Obstet & Gynecol, Daegu, South Korea; Kyungpook Natl Univ, Sch Med, Dept Obstet & Gynecol, 680 Gukchaebosang Ro, Daegu 41944, South Korea | 57360628800; 26656670100 | dghong@knu.ac.kr; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 42 | 10 | SCIE | ONCOLOGY | 2022 | 2 | 87.3 | 0 | 2025-06-25 | 0 | 0 | Ovarian cancer; pleural effusion; chemotherapy; overall survival; progression-free survival | THERAPEUTIC IMPLICATIONS; CRITERIA | chemotherapy; Ovarian cancer; overall survival; pleural effusion; progression-free survival | Carcinoma, Ovarian Epithelial; Female; Humans; Ovarian Neoplasms; Pleural Effusion; Pleural Effusion, Malignant; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; bevacizumab; carboplatin; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor; pembrolizumab; adult; advanced cancer; Article; cancer chemotherapy; cancer patient; cancer prognosis; cancer staging; cancer survival; clinical outcome; comparative study; controlled study; female; human; major clinical study; malignant pleura effusion; middle aged; ovary carcinoma; overall survival; patient selection; pleura effusion; positron emission tomography-computed tomography; progression free survival; retrospective study; survival rate; tumor biopsy; complication; malignant pleura effusion; ovary tumor; pathology; prognosis | English | 2022 | 2022-10 | 10.21873/anticanres.16000 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Correlation Between Clinical Outcomes and Serum CA-125 Levels After Standard Treatment for Epithelial Ovarian Cancer | Background/Aim: To analyze the relationship between clinical outcomes for epithelial ovarian cancer and serum CA-125 levels after chemotherapy in Korean women. Patients and Methods: This study included 183 patients who underwent the standard treatment regimen for epithelial ovarian cancer. They were divided into early- (I, II) and advanced-stage (III, IV) groups. Serum CA-125 level after CA-125) was measured. Overall survival (OS), progressionfree survival (PFS), platinum-free interval (PFI), and platinum resistance were evaluated. Results: In advancedstage group, OS, PFS, PFI, and platinum resistance were significantly correlated with PC-CA-125. In early-stage group, PFS and platinum resistance differed significantly. Cutoff value for platinum resistance was 10.45 U/ml, 10.40 U/ml, and 15.80 U/ml for study population, early stage, and advanced groups, respectively. Accuracy was 71.1%-77.1%. Conclusion: PC-CA-125 is correlated with clinical outcomes in ovarian cancer. Thus, CA-125 can be used to predict platinum resistance in ovarian cancer treatment. | Lee, Juhun; Kim, Jong Mi; Lee, Yoon Hee; Chong, Gun Oh; Hong, Dae Gy | Kyungpook Natl Univ, Chilgok Hosp, Dept Obstet & Gynecol, 807 Hoguk Ro, Daegu 41404, South Korea | 57360628800; 57212764251; 37088851700; 23099068000; 26656670100 | dghong@knu.ac.kr; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 42 | 1 | SCIE | ONCOLOGY | 2022 | 2 | 87.3 | 0.28 | 2025-06-25 | 3 | 3 | Ovarian cancer; chemotherapy; clinical outcomes; overall survival; progression-free survival; platinum-free interval; platinum resistance; CA-125 | NEOADJUVANT CHEMOTHERAPY; PROGRESSION; TRIAL; CA125; PACLITAXEL; CARCINOMA; CRITERIA; MARKERS | CA-125; Chemotherapy; Clinical outcomes; Ovarian cancer; Overall survival; Platinum resistance; Platinum-free interval; Progression-free survival | Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Middle Aged; Neoplasm Staging; Progression-Free Survival; Treatment Outcome; CA 125 antigen; carboplatin; platinum; taxane derivative; antineoplastic agent; CA 125 antigen; adjuvant chemotherapy; adult; aged; Article; biopsy; cancer adjuvant therapy; cancer chemotherapy; cancer patient; cancer staging; cancer survival; cancer therapy; chemotherapy; clinical outcome; female; human; human tissue; hysterectomy; lymph node dissection; major clinical study; male; neoadjuvant chemotherapy; omentectomy; ovariectomy; ovary cancer; ovary carcinoma; overall survival; pelvis lymphadenectomy; progression free survival; receiver operating characteristic; tumor volume; blood; disease free survival; drug resistance; drug therapy; genetics; middle aged; pathology; surgery; treatment outcome | English | 2022 | 2022-01 | 10.21873/anticanres.15492 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Effects of Cyclooxygenase-2 in Canine Melanoma-derived Extracellular Vesicles on Tumor Microenvironment In Vitro | Background/Aim: Tumor cell-derived extracellular vesicles (TEVs) promote tumor growth and metastasis; thus, they have drawn the attention of researchers. TEVs regulate the tumor microenvironment by facilitating crosstalk between immune and stromal cells. Macrophages are one of the key components involved in malignant behavior in melanomas. Generally, when activated, macrophages polarize into M1 (pro-inflammatory) or M2 (anti-inflammatory, pro-tumor) phenotypes. However, the role of canine melanoma-derived EVs in macrophage polarization is elusive. In this study, we aimed to analyze the pro- and anti-inflammatory cytokines that are common markers for M1 or M2 macrophages in vitro. Materials and Methods: The analysis was performed under coculture conditions of canine melanoma-derived (LMeC) EVs with canine macrophages ( DH82). Quantitative reverse transcription polymerase chain reaction, western blotting, and immunofluorescence were used. Results: Canine melanoma-derived EVs polarized M1 macrophages (inducible nitric oxide synthase, tumor necrosis factor a) into M2 macrophages [cluster of differentiation ( CD)206, interleukin-10] and cyclooxygenase-2 is a major factor in macrophage polarization in canine melanoma- derived EVs. Furthermore, we also found that melanoma-derived EVs induced the expression of angiogenic cytokines (vascular endothelial growth factor, transforming growth factor beta) in endothelial cells. Conclusion: Melanoma-derived EVs perform an immunomodulatory function and can be used as targets in anti-inflammatory treatment. | Kim, Na-Hyeong; An, Ju-Hyun; Lee, Jeong-Hwa; Park, Su-Min; Kim, Kyeong-Bo; Kim, Tae-Hyun; Oh, Ye-In; Seo, Kyeong-Won; Youn, Hwa-Young | Seoul Natl Univ, Dept Vet Clin Sci, Coll Vet Med, Lab Vet Internal Med, Seoul 08826, South Korea; Kangwon Natl Univ, Dept Vet Emergency & Crit Care Med, Chuncheon Si, South Korea; Kangwon Natl Univ, Coll Vet Med, Inst Vet Sci, Chuncheon Si, South Korea; Kyungpook Natl Univ, Dept Vet Internal Med, Coll Vet Med, Daegu, South Korea | Lee, Jeong-hwa/KIK-0962-2024; Kim, Tae/C-8884-2009 | 57888244200; 57206839650; 57221404340; 57211909684; 57222490396; 58961397500; 36466903200; 8833507700; 7102027331 | hyyoun@snu.ac.kr; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 42 | 11 | SCIE | ONCOLOGY | 2022 | 2 | 87.3 | 0.09 | 2025-06-25 | 1 | 2 | Dog; endothelial cell; macrophage; melanoma; tumor microenvironment | Dog; endothelial cell; macrophage; melanoma; tumor microenvironment | Animals; Cyclooxygenase 2; Cytokines; Dogs; Endothelial Cells; Extracellular Vesicles; Interleukin-10; Melanoma; Nitric Oxide Synthase Type II; Transforming Growth Factor beta; Tumor Microenvironment; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; cyclooxygenase 2; inducible nitric oxide synthase; interleukin 10; transforming growth factor beta; tumor necrosis factor; vasculotropin; cyclooxygenase 2; cytokine; inducible nitric oxide synthase; interleukin 10; transforming growth factor beta; tumor necrosis factor; vasculotropin A; animal cell; Article; coculture; controlled study; DH82 cell line; dog; endothelium cell; exosome; immunofluorescence; in vitro study; M1 macrophage; M2 macrophage; macrophage; melanoma; nonhuman; protein expression; protein function; real time reverse transcription polymerase chain reaction; tumor microenvironment; Western blotting; animal; dog; genetics; metabolism; tumor microenvironment | English | 2022 | 2022-11 | 10.21873/anticanres.16044 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea | Background/Aim: Non-small cell lung cancers (NSCLCs) harboring uncommon epidermal growth factor receptor (EGFR) mutations are heterogeneous and show variable prevalence and clinical responses to EGFR tyrosine kinase inhibitors. We investigated the characteristics of uncommon EGFR mutations and the clinical efficacy of afatinib in patients with NSCLC harboring uncommon EGFR mutations. Patients and Methods: In this multicenter, retrospective study, we analyzed patients with NSCLC with uncommon EGFR mutations in 16 South Korean institutes. Mutations were categorized according to their incidence: 1) major uncommon mutations (G719X and L861 Q), 2) compound mutations, and 3) minor uncommon mutations (exon 20 insertion, S768I, and de novo T790M). Results: Of 703 patients with EGFR-mutant NSCLC, 64 (9.1%) had uncommon EGFR mutations. Afatinib demonstrated activity against tumors harboring major uncommon mutations [median time of treatment (TOT): 20.3 months, 95% confidence interval (CI)=15.1-25.5; overall survival (OS): 30.6 months, 95% CI=26.3-34.8] and compound mutations (median TOT: 12.3 months, 95% CI=7.7-17.0; OS: 29.1 months, 95% CI=20.4-37.7) but not against tumors harboring minor uncommon mutations (median TOT: 3.8 months, 95% CI=1.7-6.0; OS: 8.5 months, 95% CI=5.211.7). The S768I mutation was present in 14 patients (1.99%). The median TOT and OS were not significantly different between S768I mutations and resistant exon 20 mutations. Conclusion: Afatinib is effective in patients with NSCLC harboring major uncommon and compound EGFR mutations. | Kim, Mi-Hyun; Choi, Chang Min; Lee, Sung Yong; Park, Cheol Kyu; Chang, Yoon Soo; Lee, Kye Young; Kim, Seung Joon; Yang, Sei Hoon; Ryu, Jeong Seon; Lee, Jeong Eun; Lee, Shin Yup; Park, Chan Kwon; Lee, Sang Hoon; Jang, Seung Hun; Yoon, Seong Hoon; Jang, Tae Won | Pusan Natl Univ, Dept Internal Med, Sch Med, Busan, South Korea; Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea; Ulsan Univ, Dept Internal Med, Asan Med Ctr, Seoul, South Korea; Korea Univ, Dept Internal Med, Div Pulmonol Allergy & Crit Care Med, Guro Hosp, Seoul, South Korea; Chonnam Natl Univ, Dept Internal Med, Hwasun Hosp, Hwasun, South Korea; Yonsei Univ, Dept Internal Med, Gangnam Severance Hosp, Seoul, South Korea; Konkuk Univ, Dept Internal Med, Med Ctr, Seoul, South Korea; Catholic Univ, Dept Internal Med, Seoul St Marys Hosp, Seoul, South Korea; Wonkwang Univ Hosp, Dept Internal Med, Iksan, South Korea; Inha Univ Hosp, Dept Internal Med, Incheon, South Korea; Chungnam Natl Univ, Dept Internal Med, Daejeon, South Korea; Kyungpook Natl Univ, Dept Internal Med, Chilgok Hosp, Daegu, South Korea; Catholic Univ, Dept Internal Med, Yeoudo St Marys Hosp, Seoul, South Korea; Yonsei Univ, Dept Internal Med, Severance Hosp, Seoul, South Korea; Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea; Pusan Natl Univ, Dept Internal Med, Yangsan Hosp, Yangsan, South Korea; Kosin Univ, Coll Med, Dept Internal Med, Gospel Hosp, Busan, South Korea | ; Park, Cheol-Kyu/AAT-9872-2021; Lee, Joo Yong/ADE-2110-2022; Kim, Woo/A-8216-2019; Lee, Jeong Eun/R-8689-2019; Kim, Jung Oh/JDC-5061-2023; Lee, Sang-Hoon/ABH-6210-2020 | 26323727500; 14024046800; 56734650000; 57205721111; 58293916800; 8720534800; 57225930594; 7406950928; 7401868634; 57209104622; 49863712700; 14623269200; 57207065392; 7402219050; 55479240500; 7102426031 | jangtw22@hanmail.net; | ANTICANCER RESEARCH | ANTICANCER RES | 0250-7005 | 1791-7530 | 42 | 3 | SCIE | ONCOLOGY | 2022 | 2 | 87.3 | 0.66 | 2025-06-25 | 7 | 7 | Lung neoplasms; epidermal growth factor receptor; afatinib; prognosis | TYROSINE KINASE INHIBITORS; FACTOR RECEPTOR MUTATIONS; RETROSPECTIVE ANALYSIS; ADENOCARCINOMA; NSCLC; CHEMOTHERAPY; EFFICACY | Afatinib; Epidermal growth factor receptor; Lung neoplasms; Prognosis | Adult; Afatinib; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Exons; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Protein Kinase Inhibitors; Retrospective Studies; Seoul; Time Factors; Treatment Outcome; afatinib; epidermal growth factor receptor; afatinib; antineoplastic agent; EGFR protein, human; epidermal growth factor receptor; protein kinase inhibitor; tumor marker; adult; aged; Article; computer assisted tomography; disease control; drug efficacy; ECOG Performance Status; electronic medical record; female; follow up; histology; human; major clinical study; male; metastasis; multicenter study; mutation; non small cell lung cancer; overall survival; real time polymerase chain reaction; response evaluation criteria in solid tumors; retrospective study; South Korea; very elderly; clinical trial; comparative study; exon; genetics; lung tumor; middle aged; mortality; non small cell lung cancer; pathology; South Korea; time factor; treatment outcome | English | 2022 | 2022-03 | 10.21873/anticanres.15636 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | Anisakiasis in Palatine Tonsil | Anisakiasis is a parasitic infection caused by ingesting raw or undercooked fish and seafood infected with Anisakis larvae. Anisakis genus is mostly found in the mucosal or submucosal layer of the stomach and intestine. However, the reports of anisakiasis in tonsils are highly uncommon. A 54-year-old woman with clinical features of sore throat and foreign-body sensation for 10 days after eating raw and undercooked fish. A wriggling worm was noted beneath the mucosa of the right palatine tonsil upon endoscopic examination. The worm was immediately removed completely and histological examination revealed anisakiasis. Reports of anisakia-sis in the tonsils are scarce, but it should be considered at the initial physical examination of patients who visit the hospital for sore throat after eating raw fish. We report a case of anisakiasis in the palatine tonsils, which to date has been rarely reported in the literature. | Cha, Eun Joo; Kim, Jung Soo; Heo, Sung Jae | Kyungpook Natl Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea | 허, 성재/AAU-3921-2020 | 57917778300; 55720132500; 55822906000 | blueskyhsj@hanmail.net; | JOURNAL OF CRANIOFACIAL SURGERY | J CRANIOFAC SURG | 1049-2275 | 1536-3732 | 33 | 7 | SCIE | SURGERY | 2022 | 0.9 | 87.6 | 0.22 | 2025-06-25 | 1 | 1 | Anisakiasis; Anisakis; endoscopy; tonsil | Anisakiasis; Anisakis; endoscopy; tonsil | Animals; Anisakiasis; Anisakis; Humans; Larva; Palatine Tonsil; Pharyngitis; Seafood; animal; anisakiasis; Anisakis; case report; human; larva; palatine tonsil; parasitology; pathology; pharyngitis; sea food | English | 2022 | 2022-10 | 10.1097/scs.0000000000008580 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Correction of a Secondary Bilateral Cleft Lip Nasal Deformity in Adults Using Repositioning of Both Lower Lateral Cartilages and Nasal Tip Plasty Through an Open Bilateral Reverse-U Incision | Background: Correcting a secondary bilateral cleft lip nasal deformity is very complex with many challenges due to its complexity. This study presents the surgical results after correcting a secondary bilateral cleft lip nasal deformity using isolation and repositioning of the lower lateral cartilages, the columellar strut, and an onlay graft on the nasal tip. Method: Eighteen patients who had bilateral cleft lip nasal deformities and who had surgery performed between September 2013 and December 2019 were included in this study. The age of the patients ranged between 19 and 52 years. Open rhinoplasty with bilateral reverse-U incision was performed. The lower lateral cartilages were isolated and repositioned. Nasal tip support is provided using a columellar strut with a septal cartilage or Medpor strut. In the vertical component of the nasal tip, a conchal cartilage graft was used. The mean follow-up period was 2 years (ranging from 1 to 6 years). Results: Fourteen of the 18 patients underwent photogrammetric evaluation. After surgery, the projection of the nasal tip and angle increased, but nasal bridge length decreased. The columella-labial angle significantly increased by 10.1% after surgery which was statistically significant (P < 0.05). The angle between the nostril axes significantly decreased by 46.2% postoperatively and also reached statistical significance (P < 0.05), indicating that the displaced alar base and lower nostril sill improved and the major axis of the nostril changed more vertically oblique. All patients were pleased with their surgical results. Conclusion: The proposed technique was highly effective in correcting secondary bilateral cleft lip nasal deformities in adults. | Ryu, Jeong Yeop; Lee, Jung Ho; Lee, Joon Seok; Lee, Jeong Woo; Choi, Kang Young; Cho, Byung Chae | Kyungpook Natl Univ, Dept Plast & Reconstruct Surg, Sch Med, 807 Hoguk Ro, Daegu 41404, South Korea | Ryu, Jeong Yeop/GLQ-9419-2022; LEE, JIN/Q-3108-2018; Lee, Jungho/AAJ-7137-2020 | 56366349400; 57202925792; 56496041000; 55892173700; 57203745682; 55662871100 | bccho@knu.ac.kr; | JOURNAL OF CRANIOFACIAL SURGERY | J CRANIOFAC SURG | 1049-2275 | 1536-3732 | 33 | 2 | SCIE | SURGERY | 2022 | 0.9 | 87.6 | 0.88 | 2025-06-25 | 4 | 4 | Bilateral cleft lip; nasal deformity | COLUMELLAR STRUT GRAFT; SEPTAL EXTENSION GRAFT; PRIMARY REPAIR; NOSE; RHINOPLASTY; FLAPS; RECONSTRUCTION; ELONGATION; SURGERY | Bilateral cleft lip; Nasal deformity | Adult; Cartilage; Cleft Lip; Drug Repositioning; Humans; Middle Aged; Nasal Cartilages; Nasal Septum; Nose; Rhinoplasty; Surgical Wound; Treatment Outcome; Young Adult; adult; cartilage; cleft lip; complication; drug repositioning; human; middle aged; nose; nose cartilage; nose septum; procedures; rhinoplasty; surgical wound; transplantation; treatment outcome; young adult | English | 2022 | 2022 (MAR-APR) | 10.1097/scs.0000000000008265 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | Correction of Severe Secondary Cleft Lip Nasal Deformity | Background: The lower lateral cartilages (LLCs) are key elements for alar and tip support. Repositioning of both LLCs is an effective procedure for correcting a laterally spreading dome of LLCs and drooping nasal tip in cleft lip nasal deformity (CLND). The alar contour graft has become an essential component of rhinoplasty for correcting the concave or collapsed and retracted alar. Herein, onlay cartilage graft was combined with nasal tip plasty to correct hypoplastic cleft lateral crus or alar rim retraction, and with columella strut to obtain better aesthetic outcomes in patients with severe CLND. Methods: Seven patients with severe secondary unilateral CLND, including hypoplastic cleft lateral crus or alar rim retraction, underwent rhinoplasty from October 2013 to April 2020. Both LLCs were isolated and repositioned approximated medially using tip suture technique combined with columella strut. A septal cartilage onlay graft was applied on the hypoplastic cleft lateral crus. Cartilage graft on the nasal tip was performed to further project and enhance the nasal tip. Photogrammetric evaluation of the operated patients and statistical analysis of the obtained data were performed. Results: The average age at operation was 23.5 (range: 17-36) years. The follow-up period was 6-36 (mean, 14.3) months. All patients were enrolled by photogrammetric evaluation. Height of the medial nostril and short axis of the nostril on the cleft side were increased with a statistical significance of P < 0.05, indicating that depressed ala on the cleft side, which is a feature of CLND, was corrected similar to that of the noncleft side. Conclusions: The alar contour cartilage graft, as an effective adjunctive technique, improves the alar margin, prevents the alar rim from collapsing, and provides supports to the cleft-side alar rim. It can be a prophylactic measure to prevent postoperative retraction in patients with weakened LLCs. Lower lateral cartilage repositioning, columellar strut, and nasal tip plasty are useful for correcting severe secondary unilateral CLND | Cho, Byung Chae; Park, Tae Hyun; Ryu, Jeong Yeop; Lee, Joon Seok; Choi, Kang Young; Yang, Jung Dug; Chung, Ho Yun | Kyungpook Natl Univ, Sch Med, Dept Plast & Reconstruct Surg, 130 Dongdeok Ro, Daegu 41944, South Korea | Ryu, Jeong Yeop/GLQ-9419-2022; Yang, Jung/R-7806-2019; LEE, JIN/Q-3108-2018 | 55662871100; 57223690181; 56366349400; 56496041000; 57203745682; 55171704700; 7404007181 | bccho@knu.ac.kr; | JOURNAL OF CRANIOFACIAL SURGERY | J CRANIOFAC SURG | 1049-2275 | 1536-3732 | 33 | 2 | SCIE | SURGERY | 2022 | 0.9 | 87.6 | 0.88 | 2025-06-25 | 4 | 4 | Cleft lip nasal deformity; lower lateral cartilage; nasal tip plasty; onlay graft | REVERSE-U INCISION; COLUMELLAR STRUT GRAFT; EVIDENCE-BASED MEDICINE; ONLAY CARTILAGE GRAFT; ALAR RIM; OPEN RHINOPLASTY; TIP; REPAIR; MANAGEMENT; PLASTY | Cleft lip nasal deformity; Lower lateral cartilage; Nasal tip plasty; Onlay graft | Cleft Lip; Esthetics, Dental; Humans; Nasal Cartilages; Nasal Septum; Nose; Rhinoplasty; Treatment Outcome; cleft lip; complication; dental procedure; human; nose; nose cartilage; nose septum; procedures; rhinoplasty; treatment outcome | English | 2022 | 2022 (MAR-APR) | 10.1097/scs.0000000000008311 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | Extracranial Craniopharyngioma Confined to the Sphenoid Sinus | Craniopharyngioma is rare epithelial tumor that develops along the craniopharyngeal duct, and most of these tumors occur in the sellar and suprasellar regions. Although it rarely occurs in the extracranial region, sphenoid solitary lesions were not reported in previous literature. In this study, we report a case of infrasellar craniopharyngioma within the sphenoid sinus without intracranial lesion. A patient with intermittent headache visited a private clinic and presented with sphenoid lesions based on the Magnetic resonance imaging scan results. The mass was completely removed using endoscopic endonasal transsphenoidal approach without any complications and showed characteristic pathologic findings, which lead to the diagnosis of craniopharyngioma. | Ko, Min Chul; Kim, Jung Soo; Kim, Mee-Seon; Heo, Sung Jae | Kyungpook Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea; Kyungpook Natl Univ, Sch Med, Dept Pathol, Daegu, South Korea | 허, 성재/AAU-3921-2020 | 57217197953; 55720132500; 56123006700; 55822906000 | blueskyhsj@hanmail.net; | JOURNAL OF CRANIOFACIAL SURGERY | J CRANIOFAC SURG | 1049-2275 | 1536-3732 | 33 | 5 | SCIE | SURGERY | 2022 | 0.9 | 87.6 | 0 | 2025-06-25 | 0 | 0 | Craniopharyngioma; sphenoid sinus | Craniopharyngioma; sphenoid sinus | Craniopharyngioma; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Sphenoid Bone; Sphenoid Sinus; case report; craniopharyngioma; diagnostic imaging; human; hypophysis tumor; nuclear magnetic resonance imaging; pathology; sphenoid; sphenoid sinus | English | 2022 | 2022 (JUL-AUG) | 10.1097/scs.0000000000008660 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Patient Discomfort After Rhinoplasty With and Without Osteotomy Under Conscious Sedation | Objective: Many rhinoplasty techniques, including dorsum augmentation and tip surgery, could be performed under conscious sedation rather than general anesthesia. However, as osteotomy is an invasive procedure, it is burdensome for surgeons to perform osteotomy under conscious sedation. As patient ratings of pain and satisfaction when osteotomy is performed under conscious sedation are unknown, this study aimed to determine discomfort of osteotomy performed under conscious sedation. Methods: Patients who underwent rhinoplasty with conscious sedation were prospectively included in the study. The patients were classified into an osteotomy and a nonosteotomy group. Questionnaires with a visual analog scale ranging from 0 to 10 were utilized to assess patient pain and satisfaction. Patients were also asked whether they would choose conscious sedation for future rhinoplasty operations. To evaluate adverse events, cardiopulmonary vital signs and nausea or vomiting were assessed. Results: Forty-five patients with a mean age of 32.7 years were included in the study. The mean patients' visual analog scale scores for pain and satisfaction were 3.3 +/- 2.0 and 7.2 +/- 1.9, respectively. Most of the patients [42, (93%)] stated that they would choose conscious sedation again if they had further operations in the future. No significant adverse effects occurred, and there were no significant differences in patients' ratings of pain and satisfaction between osteotomy and nonosteotomy groups when conscious sedation was used. Conclusion: Patients' ratings of pain and satisfaction, and a lack of significant adverse effects, indicated that rhinoplasty can be performed under conscious sedation, even with osteotomy. | Kim, Jung Soo; Heo, Sung Jae | Kyungpook Natl Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea | 허, 성재/AAU-3921-2020 | 55720132500; 55822906000 | blueskyhsj@hanmail.net; | JOURNAL OF CRANIOFACIAL SURGERY | J CRANIOFAC SURG | 1049-2275 | 1536-3732 | 33 | 8 | SCIE | SURGERY | 2022 | 0.9 | 87.6 | 0 | 2025-06-25 | 0 | 0 | Rhinoplasty; osteotomy; conscious sedation; pain; adverse effects | ANESTHESIA; MIDAZOLAM | adverse effects; conscious sedation; osteotomy; pain; Rhinoplasty | Adult; Conscious Sedation; Humans; Osteotomy; Pain; Pain Measurement; Patient Satisfaction; Rhinoplasty; adult; conscious sedation; human; osteotomy; pain; pain measurement; patient satisfaction; procedures; rhinoplasty | English | 2022 | 2022 (NOV-DEC) | 10.1097/scs.0000000000008590 | 바로가기 | 바로가기 | 바로가기 | 바로가기 |
페이지 이동: